Table 2 Association of I-PSS and PSA with prostate cancer - univariable logistic regression
|  | Cases (n = 130) Median (25–75 percentile) | Controls (n = 130) Median (25–75 percentile) | OR (95% CI) | p |
|---|---|---|---|---|
PSA concentration (ng/mL) | 89.5 (39.1–100) | 12 (8–19) | 1.06 (1.05–1.08) | < 0.001 |
I-PSS (total score) | 14 (8–19) | 6.5 (3–12) | 1.14 (1.09–1.18) | < 0.001 |
Incomplete Emptying | 4 (1–5) | 1 (1–5) | 1.27 (1.12–1.44) |  |
Frequency (every 2 h) | 2 (0–2) | 0 (0–3) | 1.22 (1.08–1.37) |  |
Intermittency | 0 (0–1) | 0 (0–1) | 1.29 (1.02–1.64) |  |
Urgency | 2 (0–5) | 0 (0–1) | 1.41 (1.23–1.62) |  |
Weak Stream | 0 (0–2) | 0 (0–0) | 1.32 (1.12–1.55) |  |
Straining | 0 (0–1) | 0 (0–1) | 1.16 (0.98–1.38) |  |
Nocturia | 4 (3–5) | 2 (1–3) | 2.22 (1.79–2.74) |  |